High frequency repetitive transcranial magnetic stimulation can improve the quality of life and depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study

被引：0
|
作者：
Makkos, A.
Pal, E.
Aschermann, Z.
Janszky, J.
Komoly, S.
Kovacs, N.
机构：
来源：
MOVEMENT DISORDERS | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
268
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [41] Mucuna pruriens in parkinson's disease: a double-blind, randomized, placebo-controlled, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E262 - E263
  • [42] Helicobacter pylori eradication in Parkinson's disease: A double-blind randomized placebo-controlled study
    Tan, A. H.
    Lim, S. Y.
    Mahadeva, S.
    Loke, M. F.
    Vadivelu, J. S.
    Marras, C.
    Fox, H.
    Lang, A. E.
    MOVEMENT DISORDERS, 2020, 35 : S422 - S425
  • [43] A randomized, double-blind, placebo-controlled study of atornoxetine for freezing of gait in Parkinson's disease
    Nashatizadeh, M. M.
    Jimenez, J. E.
    Davidson, A. L.
    Jankovic, J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S219 - S219
  • [44] Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study
    Pierantozzi, Mariangela
    Placidi, Fabio
    Liguori, Claudio
    Albanese, Maria
    Imbriani, Paola
    Marciani, Maria Grazia
    Mercuri, Nicola Biagio
    Stanzione, Paolo
    Stefani, Alessandro
    SLEEP MEDICINE, 2016, 21 : 140 - 144
  • [45] Vortioxetine Treatment for Depression in Alzheimer's Disease: A Randomized, Double-blind, Placebo-controlled Study
    Jeong, Hye Won
    Yoon, Kyung Hee
    Lee, Chang Hyun
    Moon, Yoo Sun
    Kim, Do Hoon
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (02) : 311 - 319
  • [46] Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease
    Barone, P.
    Poewe, W.
    Tolosa, E.
    Rascol, O.
    Massey, D.
    Debieuvre, C.
    Albrecht, S.
    MOVEMENT DISORDERS, 2009, 24 : S347 - S347
  • [47] A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Richard, I. H.
    McDermott, M. P.
    Kurlan, R.
    Lyness, J. M.
    Como, P. G.
    Pearson, N.
    Factor, S. A.
    Juncos, J.
    Ramos, C. Serrano
    Brodsky, M.
    Manning, C.
    Marsh, L.
    Shulman, L.
    Fernandez, H. H.
    Black, K. J.
    Panisset, M.
    Christine, C. W.
    Jiang, W.
    Singer, C.
    Horn, S.
    Pfeiffer, R.
    Rottenberg, D.
    Slevin, J.
    Elmer, L.
    Press, D.
    Hyson, H. C.
    McDonald, W.
    NEUROLOGY, 2012, 78 (16) : 1229 - 1236
  • [48] The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls-A randomized placebo-controlled, double-blind fMRI study
    Guse, Birgit
    Falkai, Peter
    Gruber, Oliver
    Whalley, Heather
    Gibson, Lydia
    Hasan, Alkomiet
    Obst, Katrin
    Dechent, Peter
    McIntosh, Andrew
    Suchan, Boris
    Wobrock, Thomas
    BEHAVIOURAL BRAIN RESEARCH, 2013, 237 : 300 - 307
  • [49] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
  • [50] A randomized, double-blind, placebo-controlled trial of hydrogen water in Parkinson's disease
    Yoritaka, A.
    Takanashi, M.
    Hirayama, M.
    Ohta, S.
    Hattori, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 311 - 311
12345